140 related articles for article (PubMed ID: 38135213)
1. Emulating Trials and Quantifying Bias: The Convergence of Health Technology Assessment Agency Real-World Evidence Guidance.
Chen S; Tikhonovsky N; Dhanji N; Ramagopalan S
Value Health; 2024 Feb; 27(2):265-267. PubMed ID: 38135213
[No Abstract] [Full Text] [Related]
2. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
[TBL] [Abstract][Full Text] [Related]
3. Emulating Target Trials With Real-World Data to Inform Health Technology Assessment: Findings and Lessons From an Application to Emergency Surgery.
Moler-Zapata S; Hutchings A; O'Neill S; Silverwood RJ; Grieve R
Value Health; 2023 Aug; 26(8):1164-1174. PubMed ID: 37164043
[TBL] [Abstract][Full Text] [Related]
4. The role of quantitative bias analysis for nonrandomized comparisons in health technology assessment: recommendations from an expert workshop.
Leahy TP; Durand-Zaleski I; Sampietro-Colom L; Kent S; Zöllner Y; Coyle D; Casadei G
Int J Technol Assess Health Care; 2023 Nov; 39(1):e68. PubMed ID: 37981828
[TBL] [Abstract][Full Text] [Related]
5. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13.
Bray BD; Ramagopalan SV
J Comp Eff Res; 2023 Nov; 12(11):e230141. PubMed ID: 37712636
[TBL] [Abstract][Full Text] [Related]
6. Meta-analyses using real-world data to generate clinical and epidemiological evidence: a systematic literature review of existing recommendations.
Briere JB; Bowrin K; Taieb V; Millier A; Toumi M; Coleman C
Curr Med Res Opin; 2018 Dec; 34(12):2125-2130. PubMed ID: 30217138
[TBL] [Abstract][Full Text] [Related]
7. What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward.
Kc S; Lin LW; Bayani DBS; Zemlyanska Y; Adler A; Ahn J; Chan K; Choiphel D; Genuino-Marfori AJ; Kearney B; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Akmal Shafie A; Sui B; Suwantika A; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Teerawattananon Y; Wee HL
Int J Health Policy Manag; 2023; 12():6858. PubMed ID: 37579427
[TBL] [Abstract][Full Text] [Related]
8. The use of nonrandomized evidence to estimate treatment effects in health technology assessment.
Kent S; Salcher-Konrad M; Boccia S; Bouvy JC; Waure C; Espin J; Facey K; Nguyen M; Rejon-Parrilla JC; Jonsson P
J Comp Eff Res; 2021 Oct; 10(14):1035-1043. PubMed ID: 34279114
[TBL] [Abstract][Full Text] [Related]
9. Guidance for a causal comparative effectiveness analysis emulating a target trial based on big real world evidence: when to start statin treatment.
Kuehne F; Jahn B; Conrads-Frank A; Bundo M; Arvandi M; Endel F; Popper N; Endel G; Urach C; Gyimesi M; Murray EJ; Danaei G; Gaziano TA; Pandya A; Siebert U
J Comp Eff Res; 2019 Sep; 8(12):1013-1025. PubMed ID: 31512926
[No Abstract] [Full Text] [Related]
10. GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines.
Cuello-Garcia CA; Santesso N; Morgan RL; Verbeek J; Thayer K; Ansari MT; Meerpohl J; Schwingshackl L; Katikireddi SV; Brozek JL; Reeves B; Murad MH; Falavigna M; Mustafa R; Regidor DL; Alexander PE; Garner P; Akl EA; Guyatt G; Schünemann HJ
J Clin Epidemiol; 2022 Feb; 142():200-208. PubMed ID: 34800676
[TBL] [Abstract][Full Text] [Related]
11. Regulatory and HTA Considerations for Development of Real-World Data Derived External Controls.
Curtis LH; Sola-Morales O; Heidt J; Saunders-Hastings P; Walsh L; Casso D; Oliveria S; Mercado T; Zusterzeel R; Sobel RE; Jalbert JJ; Mastey V; Harnett J; Quek RGW
Clin Pharmacol Ther; 2023 Aug; 114(2):303-315. PubMed ID: 37078264
[TBL] [Abstract][Full Text] [Related]
12. Measuring the Effectiveness of Real-World Evidence to Ensure Appropriate Impact.
Brown JP; Douglas IJ; Hanif S; Thwaites RMA; Bate A
Value Health; 2021 Sep; 24(9):1241-1244. PubMed ID: 34452702
[TBL] [Abstract][Full Text] [Related]
13. Can randomised trials rely on existing electronic data? A feasibility study to explore the value of routine data in health technology assessment.
Williams JG; Cheung WY; Cohen DR; Hutchings HA; Longo MF; Russell IT
Health Technol Assess; 2003; 7(26):iii, v-x, 1-117. PubMed ID: 14499049
[TBL] [Abstract][Full Text] [Related]
14. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 14.
Bray BD; Ramagopalan SV
J Comp Eff Res; 2024 Jan; 13(1):e230189. PubMed ID: 38179957
[TBL] [Abstract][Full Text] [Related]
15. Research methods for obtaining primary evidence.
Jaeschke R; Sackett DL
Int J Technol Assess Health Care; 1989; 5(4):503-19. PubMed ID: 2699468
[TBL] [Abstract][Full Text] [Related]
16. USING THE INTEGRATE-HTA GUIDANCE: EXPERIENCE FROM CADTH.
Bond K; Weeks L
Int J Technol Assess Health Care; 2017 Jan; 33(5):591-596. PubMed ID: 29143698
[TBL] [Abstract][Full Text] [Related]
17. Swan to phoenix: the metamorphosis.
Brandstetter RD; Grant GR; Gitler B
Heart Lung; 1998; 27(4):215-7. PubMed ID: 9713711
[No Abstract] [Full Text] [Related]
18. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2021 Jul; 10(10):797-799. PubMed ID: 33955236
[TBL] [Abstract][Full Text] [Related]
19. A Comparison of Seven Oncology External Control Arm Case Studies: Critiques From Regulatory and Health Technology Assessment Agencies.
Jaksa A; Louder A; Maksymiuk C; Vondeling GT; Martin L; Gatto N; Richards E; Yver A; Rosenlund M
Value Health; 2022 Dec; 25(12):1967-1976. PubMed ID: 35760714
[TBL] [Abstract][Full Text] [Related]
20. [GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence].
Morche J; Freitag S; Hoffmann F; Rissling O; Langer G; Nußbaumer-Streit B; Toews I; Gartlehner G; Meerpohl JJ
Z Evid Fortbild Qual Gesundhwes; 2020 Apr; 150-152():124-133. PubMed ID: 31980320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
